AdvanSix (NYSE:ASIX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.
ASIX has been the topic of several other reports. Piper Sandler set a $32.00 price target on AdvanSix in a research report on Monday, May 19th. UBS Group set a $35.00 target price on AdvanSix in a research note on Tuesday, March 18th.
Get Our Latest Report on AdvanSix
AdvanSix Stock Down 2.0%
Insider Buying and Selling at AdvanSix
In other AdvanSix news, SVP Achilles B. Kintiroglou sold 4,000 shares of the business’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $22.24, for a total value of $88,960.00. Following the transaction, the senior vice president now owns 36,363 shares in the company, valued at $808,713.12. The trade was a 9.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 5.60% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC lifted its holdings in AdvanSix by 149.5% in the 1st quarter. GAMMA Investing LLC now owns 1,966 shares of the company’s stock worth $45,000 after purchasing an additional 1,178 shares during the last quarter. AlphaQuest LLC acquired a new position in AdvanSix during the fourth quarter valued at approximately $94,000. Quantbot Technologies LP grew its holdings in AdvanSix by 33.2% during the first quarter. Quantbot Technologies LP now owns 4,096 shares of the company’s stock valued at $93,000 after purchasing an additional 1,022 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in AdvanSix during the fourth quarter valued at approximately $137,000. Finally, State of Wyoming acquired a new position in AdvanSix during the fourth quarter valued at approximately $156,000. 86.39% of the stock is owned by institutional investors.
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Recommended Stories
- Five stocks we like better than AdvanSix
- What is a support level?
- Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet
- Energy and Oil Stocks Explained
- e.l.f. Gets Back on the Shelf! It’s Not Too Late to Buy In!
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.